References
- Ingsathit A, Avihingsanon Y, Rattanasiri S, et al. Different etiologies of graft loss and death in Asian kidney transplant recipients: a report from Thai Transplant Registry. Transplant Proc 42:4014-4016, 2010 https://doi.org/10.1016/j.transproceed.2010.09.061
- Tanabe K. Interinstitutional variation in the measurement of anti-A/B antibodies: the Japanese ABO-Incompatible Transplantation Committee survey. Transplantation 84(12 Suppl):S13- S16, 2007 https://doi.org/10.1097/01.tp.0000296018.82857.ef
- Fehr T, Cippa PE, Mueller NJ. Cytomegalovirus post kidney transplantation: prophylaxis versus pre-emptive therapy? Transpl Int 28:1351-1356, 2015 https://doi.org/10.1111/tri.12629
- Kotton CN, Kumar D, Caliendo AM; Transplantation Society International CMV Consensus Group, et al. International consensus guidelines on the management of cytomegalovirus in solid organ transplantation. Transplantation 89:779-795, 2010 https://doi.org/10.1097/TP.0b013e3181cee42f
- Sumethkul V, Ingsathit A, Jirasiritham S. Ten-year followup of kidney transplantation from hepatitis B surface antigen-positive donors. Transplant Proc 41:213-215, 2009 https://doi.org/10.1016/j.transproceed.2008.09.056
- Lee J, Cho JH, Lee JS, et al. Pretransplant hepatitis B viral infection increases risk of death after kidney transplantation: a multicenter cohort study in Korea. Medicine (Baltimore) 95:e3671, 2016 https://doi.org/10.1097/MD.0000000000003671
- Chancharoenthana W, Townamchai N, Pongpirul K, et al. The outcomes of kidney transplantation in hepatitis B surface antigen (HBsAg)-negative recipients receiving graft from HBsAg-positive donors: a retrospective, propensity score-matched study. Am J Transplant 14:2814-2820, 2014 https://doi.org/10.1111/ajt.12921
- Locke JE, James NT, Mannon RB, et al. Immunosuppression regimen and the risk of acute rejection in HIV-infected kidney transplant recipients. Transplantation 97:446- 450, 2014 https://doi.org/10.1097/01.TP.0000436905.54640.8c
- Boyarsky BJ, Durand CM, Palella FJ Jr, Segev DL. Challenges and clinical decision-making in HIV-to-HIV transplantation: insights from the HIV literature. Am J Transplant 15:2023-2030, 2015 https://doi.org/10.1111/ajt.13344
- Haywood AM. Virus receptors: binding, adhesion strengthening, and changes in viral structure. J Virol 68:1-5, 1994
- Traylen CM, Patel HR, Fondaw W, et al. Virus reactivation: a panoramic view in human infections. Future Virol 6:451- 463, 2011 https://doi.org/10.2217/fvl.11.21
- Knipe DM, Howley PM, Griffin DE. Fundamental Virology, 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2001
- Pang IK, Iwasaki A. Control of antiviral immunity by pattern recognition and the microbiome. Immunol Rev 245: 209-226, 2012 https://doi.org/10.1111/j.1600-065X.2011.01073.x
- van de Berg PJ, van Leeuwen EM, ten Berge IJ, van Lier R. Cytotoxic human CD4(+) T cells. Curr Opin Immunol 20: 339-343, 2008 https://doi.org/10.1016/j.coi.2008.03.007
- Chappell JD, Dermody TS. 134 - Biology of viruses and viral diseases. In: Bennett JE, Dolin R, Blaser MJ, eds. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 8th ed. Philadelphia: Elsevier Saunders, 1681-1693, 2015
- Randall RE, Griffin DE. Within host RNA virus persistence: mechanisms and consequences. Curr Opin Virol 23:35-42, 2017 https://doi.org/10.1016/j.coviro.2017.03.001
- Kane M, Golovkina T. Common threads in persistent viral infections. J Virol 84:4116-4123, 2010 https://doi.org/10.1128/JVI.01905-09
- Khanna KM, Lepisto AJ, Hendricks RL. Immunity to latent viral infection: many skirmishes but few fatalities. Trends Immunol 25:230-234, 2004 https://doi.org/10.1016/j.it.2004.02.010
- Humar A. Reactivation of viruses in solid organ transplant patients receiving cytomegalovirus prophylaxis. Transplantation 82(2 Suppl):S9-S14, 2006
- Freeman RB Jr. The 'indirect' effects of cytomegalovirus infection. Am J Transplant 9:2453-2458, 2009 https://doi.org/10.1111/j.1600-6143.2009.02824.x
- Roman A, Manito N, Campistol JM, et al. The impact of the prevention strategies on the indirect effects of CMV infection in solid organ transplant recipients. Transplant Rev (Orlando) 28:84-91, 2014 https://doi.org/10.1016/j.trre.2014.01.001
- Carrillo-Infante C, Abbadessa G, Bagella L, Giordano A. Viral infections as a cause of cancer (review). Int J Oncol 30:1521-1528, 2007
- Fehervari Z, Sakaguchi S. CD4+ Tregs and immune control. J Clin Invest 114:1209-1217, 2004 https://doi.org/10.1172/JCI200423395
- Razonable RR, Humar A; AST Infectious Diseases Community of Practice. Cytomegalovirus in solid organ transplantation. Am J Transplant 13 Suppl 4:93-106, 2013 https://doi.org/10.1111/ajt.12103
- Natori Y, Humar A, Husain S, et al. Recurrence of CMV Infection and the effect of prolonged antivirals in organ transplant recipients. Transplantation 101:1449-1454, 2017 https://doi.org/10.1097/TP.0000000000001338
- Nierenberg NE, Poutsiaka DD, Chow JK, et al. Pretransplant lymphopenia is a novel prognostic factor in cytomegalovirus and noncytomegalovirus invasive infections after liver transplantation. Liver Transpl 20:1497-1507, 2014
- Sarmiento E, Jaramillo M, Calahorra L, et al. Evaluation of humoral immunity profiles to identify heart recipients at risk for development of severe infections: a multicenter prospective study. J Heart Lung Transplant 36:529-539, 2017 https://doi.org/10.1016/j.healun.2016.10.004
- Fernandez-Ruiz M, Silva JT, Lopez-Medrano F, et al. Posttransplant monitoring of NK cell counts as a simple approach to predict the occurrence of opportunistic infection in liver transplant recipients. Transpl Infect Dis 18: 552-565, 2016 https://doi.org/10.1111/tid.12564
- Sarmiento E, del Pozo N, Gallego A, et al. Decreased levels of serum complement C3 and natural killer cells add to the predictive value of total immunoglobulin G for severe infection in heart transplant recipients. Transpl Infect Dis 14:526-539, 2012 https://doi.org/10.1111/j.1399-3062.2012.00757.x
- Sarmiento E, Navarro J, Fernandez-Yanez J, Palomo J, Munoz P, Carbone J. Evaluation of an immunological score to assess the risk of severe infection in heart recipients. Transpl Infect Dis 16:802-812, 2014 https://doi.org/10.1111/tid.12284
- Goldfarb NS, Avery RK, Goormastic M, et al. Hypogammaglobulinemia in lung transplant recipients. Transplantation 71:242-246, 2001 https://doi.org/10.1097/00007890-200101270-00013
- Kotton CN, Kumar D, Caliendo AM; The Transplantation Society International CMV Consensus Group, et al. The third international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation. Transplantation 102:900-931, 2018 https://doi.org/10.1097/TP.0000000000002191
- Chiasakul T, Townamchai N, Jutivorakool K, et al. Risk factors of cytomegalovirus disease in kidney transplant recipients: a single-center study in Thailand. Transplant Proc 47:2460-2464, 2015 https://doi.org/10.1016/j.transproceed.2015.08.011
- Hartmann A, Sagedal S, Hjelmesaeth J. The natural course of cytomegalovirus infection and disease in renal transplant recipients. Transplantation 82(2 Suppl):S15-S17, 2006
- De Keyzer K, Van Laecke S, Peeters P, Vanholder R. Human cytomegalovirus and kidney transplantation: a clinician's update. Am J Kidney Dis 58:118-126, 2011 https://doi.org/10.1053/j.ajkd.2011.04.010
- Lopez-Oliva MO, Flores J, Madero R, et al. Cytomegalovirus infection after kidney transplantation and long-term graft loss. Nefrologia 37:515-525, 2017 https://doi.org/10.1016/j.nefro.2016.11.018
- Brennan DC. Cytomegalovirus in renal transplantation. J Am Soc Nephrol 12:848-855, 2001
- Humar A, Lebranchu Y, Vincenti F, et al. The efficacy and safety of 200 days valganciclovir cytomegalovirus prophylaxis in high-risk kidney transplant recipients. Am J Transplant 10:1228-1237, 2010 https://doi.org/10.1111/j.1600-6143.2010.03074.x
- Khoury JA, Storch GA, Bohl DL, et al. Prophylactic versus preemptive oral valganciclovir for the management of cytomegalovirus infection in adult renal transplant recipients. Am J Transplant 6:2134-2143, 2006 https://doi.org/10.1111/j.1600-6143.2006.01413.x
- Kliem V, Fricke L, Wollbrink T, Burg M, Radermacher J, Rohde F. Improvement in long-term renal graft survival due to CMV prophylaxis with oral ganciclovir: results of a randomized clinical trial. Am J Transplant 8:975-983, 2008 https://doi.org/10.1111/j.1600-6143.2007.02133.x
- Witzke O, Nitschke M, Bartels M, et al. Valganciclovir prophylaxis versus preemptive therapy in cytomegaloviruspositive renal allograft recipients: long-term results after 7 years of a randomized clinical trial. Transplantation 102: 876-882, 2018 https://doi.org/10.1097/TP.0000000000002024
- Reischig T, Jindra P, Hes O, Svecova M, Klaboch J, Treska V. Valacyclovir prophylaxis versus preemptive valganciclovir therapy to prevent cytomegalovirus disease after renal transplantation. Am J Transplant 8:69-77, 2008
- Asberg A, Humar A, Rollag H, et al. Lessons learned from a randomized study of oral valganciclovir versus parenteral ganciclovir treatment of cytomegalovirus disease in solid organ transplant recipients: the VICTOR trial. Clin Infect Dis 62:1154-1160, 2016 https://doi.org/10.1093/cid/ciw084
- Dierickx D, Habermann TM. Post-transplantation lymphoproliferative disorders in adults. N Engl J Med 378: 549-562, 2018 https://doi.org/10.1056/NEJMra1702693
- Dierickx D, Tousseyn T, Sagaert X, et al. Single-center analysis of biopsy-confirmed posttransplant lymphoproliferative disorder: incidence, clinicopathological characteristics and prognostic factors. Leuk Lymphoma 54:2433- 2440, 2013 https://doi.org/10.3109/10428194.2013.780655
- Opelz G, Dohler B, Ruhenstroth A. Cytomegalovirus prophylaxis and graft outcome in solid organ transplantation: a collaborative transplant study report. Am J Transplant 4: 928-936, 2004 https://doi.org/10.1111/j.1600-6143.2004.00451.x
- Green M, Michaels MG. Epstein-Barr virus infection and posttransplant lymphoproliferative disorder. Am J Transplant 13 Suppl 3:41-54, 2013
- Morton M, Coupes B, Roberts SA, et al. Epstein-Barr virus infection in adult renal transplant recipients. Am J Transplant 14:1619-1629, 2014 https://doi.org/10.1111/ajt.12703
- Quinlan SC, Pfeiffer RM, Morton LM, Engels EA. Risk factors for early-onset and late-onset post-transplant lymphoproliferative disorder in kidney recipients in the United States. Am J Hematol 86:206-209, 2011 https://doi.org/10.1002/ajh.21911
- Caillard S, Lamy FX, Quelen C; French Transplant Centers, et al. Epidemiology of posttransplant lymphoproliferative disorders in adult kidney and kidney pancreas recipients: report of the French registry and analysis of subgroups of lymphomas. Am J Transplant 12:682-693, 2012 https://doi.org/10.1111/j.1600-6143.2011.03896.x
- Allen UD, Preiksaitis JK; AST Infectious Diseases Community of Practice. Epstein-Barr virus and posttransplant lymphoproliferative disorder in solid organ transplantation. Am J Transplant 13 Suppl 4:107-120, 2013 https://doi.org/10.1111/ajt.12104
- Hirsch HH, Randhawa P; AST Infectious Diseases Community of Practice. BK polyomavirus in solid organ transplantation. Am J Transplant 13 Suppl 4:179-188, 2013
- Ambalathingal GR, Francis RS, Smyth MJ, Smith C, Khanna R. BK Polyomavirus: clinical aspects, immune regulation, and emerging therapies. Clin Microbiol Rev 30:503- 528, 2017 https://doi.org/10.1128/CMR.00074-16
- Yooprasert P, Rotjanapan P. BK virus-associated nephropathy: current situation in a resource-limited country. Transplant Proc 50:130-136, 2018 https://doi.org/10.1016/j.transproceed.2017.11.007
- Skulratanasak P, Mahamongkhonsawata J, Chayakulkeereeb M, Larpparisutha N, Premasathiana N, Vongwiwatana A. BK virus infection in Thai kidney transplant recipients: a single-center experience. Transplant Proc 50:1077-1079, 2018 https://doi.org/10.1016/j.transproceed.2018.02.047
- Fishman JA. Infection in organ transplantation. Am J Transplant 17:856-879, 2017 https://doi.org/10.1111/ajt.14208
- Kadambi PV, Josephson MA, Williams J, et al. Treatment of refractory BK virus-associated nephropathy with cidofovir. Am J Transplant 3:186-191, 2003 https://doi.org/10.1034/j.1600-6143.2003.30202.x
- Kuypers DR, Vandooren AK, Lerut E, et al. Adjuvant lowdose cidofovir therapy for BK polyomavirus interstitial nephritis in renal transplant recipients. Am J Transplant 5: 1997-2004, 2005 https://doi.org/10.1111/j.1600-6143.2005.00980.x
- Wu SW, Chang HR, Lian JD. The effect of low-dose cidofovir on the long-term outcome of polyomavirus-associated nephropathy in renal transplant recipients. Nephrol Dial Transplant 24:1034-1038, 2009
- Nesselhauf N, Strutt J, Bastani B. Evaluation of leflunomide for the treatment of BK viremia and biopsy proven BK nephropathy; a single center experience. J Nephropathol 5:34-37, 2016
- Faguer S, Hirsch HH, Kamar N, et al. Leflunomide treatment for polyomavirus BK-associated nephropathy after kidney transplantation. Transpl Int 20:962-969, 2007 https://doi.org/10.1111/j.1432-2277.2007.00523.x
- Zaman RA, Ettenger RB, Cheam H, Malekzadeh MH, Tsai EW. A novel treatment regimen for BK viremia. Transplantation 97:1166-1171, 2014 https://doi.org/10.1097/01.TP.0000441825.72639.4f
- Johnston O, Jaswal D, Gill JS, Doucette S, Fergusson DA, Knoll GA. Treatment of polyomavirus infection in kidney transplant recipients: a systematic review. Transplantation 89:1057-1070, 2010 https://doi.org/10.1097/TP.0b013e3181d0e15e
- Arroyo D, Chandran S, Vagefi PA, Wojciechowski D. Adjuvant ciprofloxacin for persistent BK polyomavirus infection in kidney transplant recipients. J Transplant 2014: 107459, 2014
- Umbro I, Anzivino E, Tinti F, et al. Possible antiviral effect of ciprofloxacin treatment on polyomavirus BK replication and analysis of non-coding control region sequences. Virol J 10:274, 2013 https://doi.org/10.1186/1743-422X-10-274
- Lee BT, Gabardi S, Grafals M, et al. Efficacy of levofloxacin in the treatment of BK viremia: a multicenter, doubleblinded, randomized, placebo-controlled trial. Clin J Am Soc Nephrol 9:583-589, 2014 https://doi.org/10.2215/CJN.04230413
- Khalil MAM, Khalil MAU, Tan J, Khan TFT. Fluoroquinolones and BK virus nephropathy: a myth or a reality. Indian J Nephrol 28:257-264, 2018
- Townamchai N, Thongboon A, Kittikowit W, Suankratay C, Praditpornsilpa K, Avihingsanon Y. Successful treatment of polyomavirus infection in kidney allograft recipients: case reports and literature review. Asian Biomed 3:151- 157, 2009
- Vu D, Shah T, Ansari J, Naraghi R, Min D. Efficacy of intravenous immunoglobulin in the treatment of persistent BK viremia and BK virus nephropathy in renal transplant recipients. Transplant Proc 47:394-398, 2015 https://doi.org/10.1016/j.transproceed.2015.01.012
- Kable K, Davies CD, O'Connell PJ, Chapman JR, Nankivell BJ. Clearance of BK virus nephropathy by combination antiviral therapy with intravenous immunoglobulin. Trans plant Direct 3:e142, 2017 https://doi.org/10.1097/TXD.0000000000000641
- Luxemburger C, Dutta AK. Overlapping epidemiologies of Hepatitis A and typhoid fever: the needs of the traveler. J Travel Med 12 Suppl 1:S12-S21, 2005
- Franco E, Meleleo C, Serino L, Sorbara D, Zaratti L. Hepatitis A: epidemiology and prevention in developing countries. World J Hepatol 4:68-73, 2012 https://doi.org/10.4254/wjh.v4.i3.68
- Jacobsen KH, Wiersma ST. Hepatitis A virus seroprevalence by age and world region, 1990 and 2005. Vaccine 28: 6653-6657, 2010 https://doi.org/10.1016/j.vaccine.2010.08.037
- Inoue K, Yoshiba M, Yotsuyanagi H, Otsuka T, Sekiyama K, Fujita R. Chronic hepatitis A with persistent viral replication. J Med Virol 50:322-324, 1996 https://doi.org/10.1002/(SICI)1096-9071(199612)50:4<322::AID-JMV7>3.0.CO;2-A
- Abolghasemi S, Sali S, Arabsaghari E, et al. Seroprevalence of hepatitis A in hemodialysis patient candidate for kidney transplant younger than forty years. Nov Biomed 2:49-53, 2017
- Mariya FA, de Mello Perez R, Silva AE, Pestana JO, Ferraz ML. Prevalence of previous hepatitis A virus infection in renal transplant patients with hepatitis C: evidence of persistent anti-hepatitis A virus immune response. Transplant Proc 36:1500-1501, 2004 https://doi.org/10.1016/j.transproceed.2004.05.034
- Levitsky J, Doucette K; AST Infectious Diseases Community of Practice. Viral hepatitis in solid organ transplantation. Am J Transplant 13 Suppl 4:147-168, 2013 https://doi.org/10.1111/ajt.12108
- Jeon HJ, Ro H, Jeong JC, et al. Efficacy and safety of hepatitis A vaccination in kidney transplant recipients. Transpl Infect Dis 16:511-515, 2014 https://doi.org/10.1111/tid.12217
- Stark K, Gunther M, Neuhaus R, et al. Immunogenicity and safety of hepatitis A vaccine in liver and renal transplant recipients. J Infect Dis 180:2014-2017, 1999 https://doi.org/10.1086/315125
- Foster MA, Weil LM, Jin S, et al. Transmission of hepatitis A virus through combined liver-small intestine-pancreas transplantation. Emerg Infect Dis 23:590-596, 2017 https://doi.org/10.3201/eid2304.161532
- Gane E, Sallie R, Saleh M, Portmann B, Williams R. Clinical recurrence of hepatitis A following liver transplantation for acute liver failure. J Med Virol 45:35-39, 1995 https://doi.org/10.1002/jmv.1890450107
- Peng CY, Chien RN, Liaw YF. Hepatitis B virus-related decompensated liver cirrhosis: benefits of antiviral therapy. J Hepatol 57:442-450, 2012 https://doi.org/10.1016/j.jhep.2012.02.033
- Johnson DW, Dent H, Yao Q, et al. Frequencies of hepatitis B and C infections among haemodialysis and peritoneal dialysis patients in Asia-Pacific countries: analysis of registry data. Nephrol Dial Transplant 24:1598-1603, 2009 https://doi.org/10.1093/ndt/gfn684
- Blanpain C, Knoop C, Delforge ML, et al. Reactivation of hepatitis B after transplantation in patients with pre-existing anti-hepatitis B surface antigen antibodies: report on three cases and review of the literature. Transplantation 66:883-886, 1998 https://doi.org/10.1097/00007890-199810150-00012
- Degos F, Lugassy C, Degott C, et al. Hepatitis B virus and hepatitis B-related viral infection in renal transplant recipients. A prospective study of 90 patients. Gastroenterology 94:151-156, 1988 https://doi.org/10.1016/0016-5085(88)90623-3
- Lok AS, McMahon BJ. Chronic hepatitis B: update 2009. Hepatology 50:661-662, 2009 https://doi.org/10.1002/hep.23190
- Foster WQ, Murphy A, Vega DJ, Smith AL, Hott BJ, Book WM. Hepatitis B vaccination in heart transplant candidates. J Heart Lung Transplant 25:106-109, 2006 https://doi.org/10.1016/j.healun.2005.07.015
- Reddy KR, Beavers KL, Hammond SP, Lim JK, Falck-Ytter YT; American Gastroenterological Association Institute. American Gastroenterological Association Institute guideline on the prevention and treatment of hepatitis B virus reactivation during immunosuppressive drug therapy. Gastroenterology 148:215-219; quiz e16-e17, 2015 https://doi.org/10.1053/j.gastro.2014.10.039
- Fytili P, Ciesek S, Manns MP, et al. Anti-HBc seroconversion after transplantation of anti-HBc positive nonliver organs to anti-HBc negative recipients. Transplantation 81:808-809, 2006 https://doi.org/10.1097/01.tp.0000198585.51562.57
- Huprikar S, Danziger-Isakov L, Ahn J, et al. Solid organ transplantation from hepatitis B virus-positive donors: consensus guidelines for recipient management. Am J Transplant 15:1162-1172, 2015 https://doi.org/10.1111/ajt.13187
- Kim CW, Chang KM. Hepatitis C virus: virology and life cycle. Clin Mol Hepatol 19:17-25, 2013 https://doi.org/10.3350/cmh.2013.19.1.17
- Ozer Etik D, Ocal S, Boyacioglu AS. Hepatitis C infection in hemodialysis patients: a review. World J Hepatol 7:885- 895, 2015 https://doi.org/10.4254/wjh.v7.i6.885
- Morales JM, Fabrizi F. Hepatitis C and its impact on renal transplantation. Nat Rev Nephrol 11:172-182, 2015 https://doi.org/10.1038/nrneph.2015.5
- Morales JM, Marcen R, Andres A, et al. Renal transplantation in patients with hepatitis C virus antibody. A long national experience. NDT Plus 3(Suppl_2):ii41-ii46, 2010
- Terrault NA, Adey DB. The kidney transplant recipient with hepatitis C infection: pre- and posttransplantation treatment. Clin J Am Soc Nephrol 2:563-575, 2007 https://doi.org/10.2215/CJN.02930806
- Pawlotsky JM. New hepatitis C virus (HCV) drugs and the hope for a cure: concepts in anti-HCV drug development. Semin Liver Dis 34:22-29, 2014 https://doi.org/10.1055/s-0034-1371007
- Beinhardt S, Al Zoairy R, Ferenci P, et al. DAA-based antiviral treatment of patients with chronic hepatitis C in the pre- and postkidney transplantation setting. Transpl Int 29:999-1007, 2016 https://doi.org/10.1111/tri.12799
- Lin MV, Sise ME, Pavlakis M, et al. Efficacy and safety of direct acting antivirals in kidney transplant recipients with chronic hepatitis C virus infection. PLoS One 11:e0158431, 2016 https://doi.org/10.1371/journal.pone.0158431
- Burgess S, Partovi N, Yoshida EM, Erb SR, Azalgara VM, Hussaini T. Drug interactions with direct-acting antivirals for hepatitis C: implications for HIV and transplant patients. Ann Pharmacother 49:674-687, 2015 https://doi.org/10.1177/1060028015576180
- Goldberg DS, Abt PL, Blumberg EA, et al. Trial of transplantation of HCV-infected kidneys into uninfected recipients. N Engl J Med 376:2394-2395, 2017 https://doi.org/10.1056/NEJMc1705221
- Ryu WS, Bayer M, Taylor J. Assembly of hepatitis delta virus particles. J Virol 66:2310-2315, 1992
- Adil B, Fatih O, Volkan I, et al. Hepatitis B virus and hepatitis D virus recurrence in patients undergoing liver transplantation for hepatitis B virus and hepatitis B virus plus hepatitis D virus. Transplant Proc 48:2119-2123, 2016 https://doi.org/10.1016/j.transproceed.2016.02.076
- Inagaki Y, Oshiro Y, Tanaka T, et al. A nationwide survey of hepatitis E virus infection and chronic hepatitis E in liver transplant recipients in Japan. EBioMedicine 2:1607-1612, 2015 https://doi.org/10.1016/j.ebiom.2015.09.030
- Haagsma EB, Niesters HG, van den Berg AP, et al. Prevalence of hepatitis E virus infection in liver transplant recipients. Liver Transpl 15:1225-1228, 2009 https://doi.org/10.1002/lt.21819
- Kamar N, Selves J, Mansuy JM, et al. Hepatitis E virus and chronic hepatitis in organ-transplant recipients. N Engl J Med 358:811-817, 2008 https://doi.org/10.1056/NEJMoa0706992
- Koning L, Pas SD, de Man RA, et al. Clinical implications of chronic hepatitis E virus infection in heart transplant recipients. J Heart Lung Transplant 32:78-85, 2013 https://doi.org/10.1016/j.healun.2012.10.008
- Kamar N, Weclawiak H, Guilbeau-Frugier C, et al. Hepatitis E virus and the kidney in solid-organ transplant patients. Transplantation 93:617-623, 2012
- Pischke S, Suneetha PV, Baechlein C, et al. Hepatitis E virus infection as a cause of graft hepatitis in liver transplant recipients. Liver Transpl 16:74-82, 2010 https://doi.org/10.1002/lt.21958
- Kamar N, Garrouste C, Haagsma EB, et al. Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants. Gastroenterology 140:1481-1489, 2011 https://doi.org/10.1053/j.gastro.2011.02.050
- Kamar N, Rostaing L, Abravanel F, et al. Pegylated interferon- alpha for treating chronic hepatitis E virus infection after liver transplantation. Clin Infect Dis 50:e30-e33, 2010 https://doi.org/10.1086/650488
- Kamar N, Izopet J, Tripon S, et al. Ribavirin for chronic hepatitis E virus infection in transplant recipients. N Engl J Med 370:1111-1120, 2014 https://doi.org/10.1056/NEJMoa1215246
- Locke JE, Gustafson S, Mehta S, et al. Survival benefit of kidney transplantation in HIV-infected patients. Ann Surg 265:604-608, 2017 https://doi.org/10.1097/SLA.0000000000001761
- Roland ME, Barin B, Huprikar S, et al; HIVTR Study Team. Survival in HIV-positive transplant recipients compared with transplant candidates and with HIV-negative controls. AIDS 30:435-444, 2016
- Frassetto LA, Tan-Tam C, Stock PG. Renal transplantation in patients with HIV. Nat Rev Nephrol 5:582-589, 2009
- Locke JE, Mehta S, Reed RD, et al. A national study of outcomes among HIV-infected kidney transplant recipients. J Am Soc Nephrol 26:2222-2229, 2015 https://doi.org/10.1681/ASN.2014070726
- Malat GE, Ranganna KM, Sikalas N, Liu L, Jindal RM, Doyle A. High frequency of rejections in HIV-positive recipients of kidney transplantation: a single center prospective trial. Transplantation 94:1020-1024, 2012
- Stock PG, Barin B, Murphy B, et al. Outcomes of kidney transplantation in HIV-infected recipients. N Engl J Med 363:2004-2014, 2010 https://doi.org/10.1056/NEJMoa1001197
- Brehm MA, Markees TG, Daniels KA, Greiner DL, Rossini AA, Welsh RM. Direct visualization of cross-reactive effector and memory allo-specific CD8 T cells generated in response to viral infections. J Immunol 170:4077-4086, 2003 https://doi.org/10.4049/jimmunol.170.8.4077
- Tanchot C, Rosado MM, Agenes F, Freitas AA, Rocha B. Lymphocyte homeostasis. Semin Immunol 9:331-337, 1997 https://doi.org/10.1006/smim.1997.0090
- Langlois AJ, Weinhold KJ, Matthews TJ, Greenberg ML, Bolognesi DP. Detection of anti-human cell antibodies in sera from macaques immunized with whole inactivated virus. AIDS Res Hum Retroviruses 8:1641-1652, 1992 https://doi.org/10.1089/aid.1992.8.1641
- van Maarseveen EM, Crommelin HA, Mudrikova T, van den Broek MP, van Zuilen AD. Pretransplantation pharmacokinetic curves of tacrolimus in HIV-infected patients on ritonavir-containing cART: a pilot study. Transplantation 95:397-402, 2013 https://doi.org/10.1097/TP.0b013e3182734651
- Sawinski D, Shelton BA, Mehta S, et al. Impact of protease inhibitor-based anti-retroviral therapy on outcomes for HIV+ kidney transplant recipients. Am J Transplant 17: 3114-3122, 2017 https://doi.org/10.1111/ajt.14419
- Miro JM, Aguero F, Duclos-Vallee JC, et al; ESCMID Study Group of Infection in Compromised Hosts. Infections in solid organ transplant HIV-infected patients. Clin Microbiol Infect 20 Suppl 7:119-130, 2014
- Kucirka LM, Durand CM, Bae S, et al. Induction immunosuppression and clinical outcomes in kidney transplant recipients infected with human immunodeficiency virus. Am J Transplant 16:2368-2376, 2016 https://doi.org/10.1111/ajt.13840
- Lopez C, Simmons RL, Mauer SM, Najarian JS, Good RA, Gentry S. Association of renal allograft rejection with virus infections. Am J Med 56:280-289, 1974 https://doi.org/10.1016/0002-9343(74)90609-3
- Martin-Gandul C, Mueller NJ, Pascual M, Manuel O. The impact of infection on chronic allograft dysfunction and allograft survival after solid organ transplantation. Am J Transplant 15:3024-3040, 2015 https://doi.org/10.1111/ajt.13486
- Cainelli F, Vento S. Infections and solid organ transplant rejection: a cause-and-effect relationship? Lancet Infect Dis 2:539-549, 2002 https://doi.org/10.1016/S1473-3099(02)00370-5
- Borchers AT, Perez R, Kaysen G, Ansari AA, Gershwin ME. Role of cytomegalovirus infection in allograft rejection: a review of possible mechanisms. Transpl Immunol 7:75-82, 1999 https://doi.org/10.1016/S0966-3274(99)80023-9
- Karuthu S, Blumberg EA. Common infections in kidney transplant recipients. Clin J Am Soc Nephrol 7:2058-2070, 2012 https://doi.org/10.2215/CJN.04410512
- Storsley L, Gibson IW. Adenovirus interstitial nephritis and rejection in an allograft. J Am Soc Nephrol 22:1423-1427, 2011 https://doi.org/10.1681/ASN.2010090941
- Cippa PE, Schiesser M, Ekberg H, et al. Risk stratification for rejection and infection after kidney transplantation. Clin J Am Soc Nephrol 10:2213-2220, 2015 https://doi.org/10.2215/CJN.01790215
- Mallat SG, Tanios BY, Itani HS, et al. CMV and BKPyV infections in renal transplant recipients receiving an mTOR inhibitor-based regimen versus a CNI-based regimen: a systematic review and meta-analysis of randomized, controlled trials. Clin J Am Soc Nephrol 12:1321-1336, 2017 https://doi.org/10.2215/CJN.13221216
- Mesri EA, Feitelson MA, Munger K. Human viral oncogenesis: a cancer hallmarks analysis. Cell Host Microbe 15:266-282, 2014 https://doi.org/10.1016/j.chom.2014.02.011
- Morath C, Mueller M, Goldschmidt H, Schwenger V, Opelz G, Zeier M. Malignancy in renal transplantation. J Am Soc Nephrol 15:1582-1588, 2004 https://doi.org/10.1097/01.ASN.0000126194.77004.9B
- Hickman LA, Sawinski D, Guzzo T, Locke JE. Urologic malignancies in kidney transplantation. Am J Transplant 18: 13-22, 2018
- Alexiev BA, Randhawa P, Vazquez Martul E, et al. BK virus-associated urinary bladder carcinoma in transplant recipients: report of 2 cases, review of the literature, and proposed pathogenetic model. Hum Pathol 44:908-917, 2013 https://doi.org/10.1016/j.humpath.2012.09.019
- Mittal A, Colegio OR. Skin cancers in organ transplant recipients. Am J Transplant 17:2509-2530, 2017 https://doi.org/10.1111/ajt.14382
- Dantal J, Campone M. Daunting but worthy goal: reducing the de novo cancer incidence after transplantation. Transplantation 100:2569-2583, 2016 https://doi.org/10.1097/TP.0000000000001428
- Holley JL. Screening, diagnosis, and treatment of cancer in long-term dialysis patients. Clin J Am Soc Nephrol 2:604-610, 2007 https://doi.org/10.2215/CJN.03931106
- Stallone G, Schena A, Infante B, et al. Sirolimus for Kaposi's sarcoma in renal-transplant recipients. N Engl J Med 352:1317-1323, 2005 https://doi.org/10.1056/NEJMoa042831
- de Fijter JW. Cancer and mTOR inhibitors in transplant recipients. Transplantation 101:45-55, 2017
Cited by
- Simultaneous detection of opportunistic viral infections among renal transplant patients from Sina Hospital, Tehran vol.14, pp.6, 2018, https://doi.org/10.2217/fvl-2018-0192
- Ginseng increases Klotho expression by FoxO3-mediated manganese superoxide dismutase in a mouse model of tacrolimus-induced renal injury vol.11, pp.15, 2018, https://doi.org/10.18632/aging.102137
- Urobiome: In Sickness and in Health vol.7, pp.11, 2018, https://doi.org/10.3390/microorganisms7110548
- A retrospective study of the relationship between postoperative urine output and one year transplanted kidney function vol.19, pp.1, 2018, https://doi.org/10.1186/s12871-019-0904-6
- Evaluation of cell-mediated immune response by QuantiFERON Monitor Assay in kidney transplant recipients presenting with infective complications vol.99, pp.27, 2018, https://doi.org/10.1097/md.0000000000021010
- Recent Advances and Clinical Outcomes of Kidney Transplantation vol.9, pp.4, 2020, https://doi.org/10.3390/jcm9041193
- The impact of cytomegalovirus infection on clinical severity and outcomes in kidney transplant recipients with Pneumocystis jirovecii pneumonia vol.64, pp.5, 2018, https://doi.org/10.1111/1348-0421.12778
- Mycophenolic Acid Trough Concentration and Dose Are Associated with Hematologic Abnormalities but Not Rejection in Kidney Transplant Recipients vol.35, pp.24, 2018, https://doi.org/10.3346/jkms.2020.35.e185
- Prevalence, risk factors and impact of occult HCV infection on liver morbidity among haemodialysis patients: hospital-based cross-sectional study vol.55, pp.8, 2018, https://doi.org/10.1080/00365521.2020.1790649
- Two distinct cases with COVID‐19 in kidney transplant recipients vol.20, pp.8, 2020, https://doi.org/10.1111/ajt.15947
- Cervical cancer screening abnormalities in immunosuppressed renal transplant women: case-control study in Southern Brazil vol.302, pp.3, 2018, https://doi.org/10.1007/s00404-020-05621-3
- ORIENTAÇÕES RELACIONADAS AO AUTOCUIDADO EM PACIENTES TRANSPLANTADOS: UMA REVISÃO NARRATIVA vol.32, pp.3, 2018, https://doi.org/10.14450/2318-9312.v32.e3.a2020.pp179-191
- ICT-based adherence monitoring in kidney transplant recipients: a randomized controlled trial vol.20, pp.1, 2018, https://doi.org/10.1186/s12911-020-01146-6
- Antiviral treatment approaches for cytomegalovirus prevention in kidney transplant recipients: A systematic review of randomized controlled trials vol.35, pp.1, 2018, https://doi.org/10.1016/j.trre.2020.100587
- Cytomegalovirus tubulo‐glomerulitis and intratubular granuloma: Key histopathological findings in allograft cytomegalovirus infection vol.26, pp.4, 2021, https://doi.org/10.1111/nep.13810
- Epidemiology, risk factors, and outcomes associated with cytomegalovirus in adult kidney transplant recipients: A systematic literature review of real‐world evidence vol.23, pp.2, 2018, https://doi.org/10.1111/tid.13483
- Performance evaluation of the Roche cobas 6800 system for quantifying cytomegalovirus DNA in plasma and urine samples vol.138, pp.None, 2018, https://doi.org/10.1016/j.jcv.2021.104816
- Recovery of kidney function after AKI because of COVID‐19 in kidney transplant recipients vol.34, pp.6, 2021, https://doi.org/10.1111/tri.13886
- A systematic review and meta-analysis of enzyme-linked immunosorbent spot (ELISPOT) assay for BK polyomavirus immune response monitoring after kidney transplantation vol.140, pp.None, 2021, https://doi.org/10.1016/j.jcv.2021.104848
- A Current Review of the Etiology, Clinical Features, and Diagnosis of Urinary Tract Infection in Renal Transplant Patients vol.11, pp.8, 2018, https://doi.org/10.3390/diagnostics11081456